Royal DSM To Make Equity Investment In Amyris With the Purpose of Establishing

Amyris Inc.and Koninklijke DSM N.V. (Royal DSM), today announced that they have agreed for DSM to make an equity investment in Amyris.

May 8, 2017

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

Amyris Inc.and Koninklijke DSM N.V. (Royal DSM), today announced that they have agreed for DSM to make an equity investment in Amyris.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like